H-1B sponsorship profile: Biozen Therapeutics Inc. Across U.S. Department of Labor LCA disclosures, Biozen Therapeutics Inc filed 2 Labor Condition Applications covering 2 H-1B worker positions between fiscal year 2025 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (2 certified of 2 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Biozen Therapeutics Inc’s H-1B petitions range from $63,086 at the low end to $98,134 at the high end, with a petition-weighted average of $80,610. That range reflects the mix of occupations the company sponsors, led by SCIENTIST I - R&D DEPARTMENT (1 petitions at $63,086 avg), followed by INNOVATION SCIENTIST, ANALYTICAL RESEARCH AND DEVELOPMENT. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Biozen Therapeutics Inc is headquartered in MONROE TOWNSHIP, NJ under NAICS code 325414, and places H-1B workers across 1 state, most heavily in NJ. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Biozen Therapeutics Inc ranks. By H-1B petition volume, Biozen Therapeutics Inc is #48,558 of 119,880 employers nationally and #2,974 of 5,818 employers headquartered in NJ. Both ranks are computed live from the same underlying petition counts, not a separate estimate.